Recombinant Poxvirus Generation via Inducer Constraints
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for generating and purifying recombinant poxviruses, such as vaccinia virus, are time-consuming, cumbersome, and often require specialized cell lines or equipment, hindering rapid vaccine development.
Innovation Solution
The Efficient Purification by Parental Inducer Constraint (EPPIC) platform uses a replication-inducible VACV as a parental virus for homologous recombination, allowing for rapid generation and purification of recombinant poxviruses through serial passages in standard laboratory cell lines without specialized equipment, utilizing inducer constraints for purification.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If traditional methods are used for generating and purifying recombinant poxviruses, then the process is reliable and produces accurate results, but the process is time-consuming and cumbersome
Solution Approach 1:
The patent divides the virus purification process into distinct segments using different inducers (tetracycline for parental virus, isopropyl β-D-1-thiogalactopyranoside for recombinant virus). This segmentation allows selective induction of recombinant virus while suppressing parental virus, enabling faster purification without requiring multiple sequential purification steps
Solution Approach 2:
The patent changes the inducer parameter between purification steps. By switching from tetracycline-induced parental virus to isopropyl β-D-1-thiogalactopyranoside-induced recombinant virus, the system rapidly shifts which virus type is actively replicated, dramatically reducing the time needed to generate pure recombinant virus populations
2Productivity
If traditional purification methods are used, then thorough purification is achieved, but specialized cell lines or equipment are required
Solution Approach 1:
The patent makes the virus system self-service by incorporating inducible expression systems directly into the viral genomes. The viruses themselves control their own induction and replication in response to chemical inducers, eliminating the need for external specialized equipment or complex cell line requirements. Standard cell lines can be used because the inducible systems are built into the viruses
Solution Approach 2:
By changing the inducer parameter (from tetracycline to isopropyl β-D-1-thiogalactopyranoside), the system simplifies the infrastructure requirements. The same standard cell lines can produce both parental and recombinant viruses by simply changing the chemical inducer, eliminating the need for specialized cell lines or equipment
3Loss of time
If rapid generation of recombinant viruses is achieved, then vaccine development is accelerated, but purification efficiency may be compromised
Solution Approach 1:
The patent converts the potential harm of parental virus contamination into a benefit by using inducer constraints. The parental virus, which could contaminate the recombinant virus preparation, is actually used as a tool for purification. By switching inducers, the parental virus is selectively suppressed while recombinant virus is induced, turning a contamination problem into a purification mechanism
Solution Approach 2:
The system uses feedback through inducer response. The parental and recombinant viruses have linked inducer responses, creating a feedback mechanism where induction of one virus type suppresses the other. This feedback loop ensures that as recombinant virus is induced, parental virus is automatically suppressed, maintaining purification efficiency throughout the rapid generation process
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables the rapid development, updating, and refinement of personalized or custom vaccines and therapeutic vectors within days, achieving efficient and streamlined production of recombinant poxviruses with or without screening markers.
Implementation Method 1
homologously recombining a replication-inducible VACV (vIND) parental virus and a DNA shuttle vector to generate the rVACVs
Implementation Method 2
transfecting the DNA shuttle vector into parental vIND
Implementation Method 3
purifying comprises a first purification step and a second purification step. For example, in some embodiments, the first purification step and the second purification step each independently comprise infecting parental VACV-infected cells with cell lysate
Implementation Method 4
transfecting comprises adding one or more inducers. In some embodiments, the inducer is an rVACV inducer. In some such embodiments, the rVACV inducer is a tetracycline antibiotic. In some embodiments, the inducer is a parental inducer. An exemplary parental inducer is isopropyl β-D-1-thiogalactopyranoside (IPTG)
Implementation Method 5
The recombinant rVACVs further express enhanced green fluorescence protein. In some such embodiments, the methods further comprise collecting enhanced green fluorescence protein (EGFP+) plaques between the first purification step and the second purification step
Data Source
AI summary
Disclosed herein are methods for the rapid generation of recombinant poxviruses, for example, to enable vaccine development.